First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - XANTEK BIOLOGICALS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: XANTEK BIOLOGICALS LIMITED, 1ST FLOOR, GATEWAY HOUSE 4 PENMAN WAY, GROVE PARK, ENDERBY, LEICESTER, LE19 1SY. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 31 December 2015. The company was incorporated on 22 April 2008.

The accounts next due date is 30 September 2017. There are no mortgages.

The above was based on public record information as at 10 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 06573345
Date Incorporated: 22 April 2008
Date Latest Accounts: 31 December 2015
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 06573345
Annual Return: 22 April 2016
Registered Office: 1ST FLOOR, GATEWAY HOUSE 4 PENMAN WAY, GROVE PARK, ENDERBY, LEICESTER, LE19 1SY
SIC Code and Operations: 21100
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

XANTEK BIOLOGICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 20 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
15211555 XANTEK WHOLESALE SUPPLIES LIMITED Active
10059061 XANTEMIS LTD Dissolved
10435714 XANTEN CONTRACTING LTD Active - Proposal to Strike off
05023086 XANTER LIMITED Active
10773801 XANTERAC LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd